These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6341393)

  • 1. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
    Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.
    Coxe JS; O'Dorisio TM; Cataland S; Crockett SE
    J Clin Endocrinol Metab; 1981 May; 52(5):1002-5. PubMed ID: 7014585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R; Frerichs H; Creutzfeldt W
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
    Ross SA; Brown JC; Dupré J
    Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
    Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
    J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S; Regeur L; Faber OK; Tronier B
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.
    Mazzaferri EL; Starich GH; St Jeor ST
    J Clin Endocrinol Metab; 1984 Apr; 58(4):640-5. PubMed ID: 6365944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics.
    Krarup T; Holst JJ; Madsbad S
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):74-83. PubMed ID: 3544634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics.
    Krarup T; Madsbad S; Moody AJ
    Acta Med Scand; 1988; 223(5):437-41. PubMed ID: 3287838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
    Creutzfeldt W; Talaulicar M; Ebert R; Willms B
    Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE; Mazzaferri EL; Cataland S
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
    Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
    J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
    Ebert R; Creutzfeldt W
    Acta Diabetol Lat; 1989; 26(1):1-15. PubMed ID: 2665406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
    Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
    Levitt NS; Vinik AI; Child PT
    J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary fibre on blood glucose, plasma immunoreactive insulin, C-peptide and GIP responses in non insulin dependent (type 2) diabetics and controls.
    Hagander B; Scherstén B; Asp NG; Sartor G; Agardh CD; Schrezenmeir J; Kasper H; Ahrén B; Lundquist I
    Acta Med Scand; 1984; 215(3):205-13. PubMed ID: 6328896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics.
    Krarup T; Madsbad S; Regeur L; Alberti KG; Faber OK; Kurtz A
    Diabete Metab; 1985 Dec; 11(6):364-7. PubMed ID: 3910488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
    Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.